Published in J Mater Sci Mater Med on May 11, 2012
Role of platelet-derived growth factors in physiology and medicine. Genes Dev (2008) 8.89
Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest (2005) 2.80
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
Current concepts of molecular aspects of bone healing. Injury (2005) 2.56
Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater (2008) 2.54
Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res (2007) 1.77
Polymeric growth factor delivery strategies for tissue engineering. Pharm Res (2003) 1.74
Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am (2008) 1.66
Note on a Method of Determining the Distribution of Pore Sizes in a Porous Material. Proc Natl Acad Sci U S A (1921) 1.45
Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone (1994) 1.31
Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity. Circulation (2006) 1.19
Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. J Control Release (2000) 1.11
Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Control Release (2002) 1.11
Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res (2008) 1.10
Expression of platelet-derived growth factor-beta receptors on human fibroblasts. Regulation by recombinant platelet-derived growth factor-BB, IL-1, and tumor necrosis factor-alpha. J Immunol (1992) 1.08
In vitro-in vivo characterization of gentamicin bone implants. J Control Release (2002) 1.02
Adsorption and release of insulin-like growth factor-I on porous tricalcium phosphate implant. J Biomed Mater Res (2000) 1.00
Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo. PLoS One (2008) 0.98
Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis. J Bone Joint Surg Am (2009) 0.93
Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. J Control Release (2009) 0.92
The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier. J Periodontol (2000) 0.88
Regulation of human bone sialoprotein gene transcription by platelet-derived growth factor-BB. Gene (2009) 0.84
Radiolabelled biodegradable microspheres for lung imaging. Eur J Pharm Biopharm (2000) 0.84
Effect of triple growth factor controlled delivery by a brushite-PLGA system on a bone defect. Injury (2011) 0.82
IL-1 down-regulates platelet-derived growth factor-alpha receptor gene expression at the transcriptional level in human osteoblastic cells. J Immunol (1994) 0.81
Preparation and properties of macroporous brushite bone cements. Acta Biomater (2009) 0.79
Reliability of clinical guidelines in the detection of patients at risk following mild head injury: results of a prospective study. J Neurosurg (2004) 3.10
Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays. Mod Pathol (2006) 1.27
A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr (2007) 1.26
Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study. Sleep Med (2007) 1.06
Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFkappaB transcription factors. J Pathol (2004) 0.97
Oestrogen receptor alpha and beta in female rat pituitary cells: an immunochemical study. Gen Comp Endocrinol (2007) 0.93
Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. J Control Release (2009) 0.92
Development of a real-time reverse transcription polymerase chain reaction assay for c-myc expression that allows the identification of a subset of c-myc+ diffuse large B-cell lymphoma. Lab Invest (2003) 0.89
Material-related effects of BMP-2 delivery systems on bone regeneration. Acta Biomater (2011) 0.88
Deregulated expression of the polycomb-group protein SUZ12 target genes characterizes mantle cell lymphoma. Am J Pathol (2010) 0.87
In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system. J Biomed Mater Res A (2012) 0.87
Isoquercitrin from Argemone platyceras inhibits carbachol and leukotriene D4-induced contraction in guinea-pig airways. Eur J Pharmacol (2005) 0.85
Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene. Eur J Cancer (2007) 0.85
Validation of a method for non-invasive in vivo measurement of growth factor release from a local delivery system in bone. J Control Release (2006) 0.83
Angiogenesis in symptomatic intracranial atherosclerosis: predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence. Stroke (2004) 0.83
Cartilage repair by local delivery of transforming growth factor-β1 or bone morphogenetic protein-2 from a novel, segmented polyurethane/polylactic-co-glycolic bilayered scaffold. J Biomed Mater Res A (2013) 0.82
VEGF-controlled release within a bone defect from alginate/chitosan/PLA-H scaffolds. Eur J Pharm Biopharm (2009) 0.82
Effect of triple growth factor controlled delivery by a brushite-PLGA system on a bone defect. Injury (2011) 0.82
BMP-2, PDGF-BB, and bone marrow mesenchymal cells in a macroporous β-TCP scaffold for critical-size bone defect repair in rats. Biomed Mater (2015) 0.79
Long-term follow-up of Symphony nitinol stents in iliac arteriosclerosis obliterans. Minim Invasive Ther Allied Technol (2008) 0.78
Endovascular repair of brachial artery transection associated with trauma. J Trauma (2004) 0.77
Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution. J Microencapsul (2013) 0.77
Characterization of estrogen receptors alpha and beta in uterine leiomyoma cells. Fertil Steril (2006) 0.76
Comparative analysis of the ERα/ERβ ratio and neurotensin and its high-affinity receptor in myometrium, uterine leiomyoma, atypical leiomyoma, and leiomyosarcoma. Int J Gynecol Pathol (2011) 0.76
Neurotensin and neurotensin receptor 1 expression in human myometrium and uterine leiomyomas. Biol Reprod (2010) 0.76
Differential expression of new splice variants of the neurotensin receptor 1 gene in human prostate cancer cell lines. Peptides (2009) 0.76
Smurf1 knocked-down, mesenchymal stem cells and BMP-2 in an electrospun system for bone regeneration. Biomacromolecules (2014) 0.76
[Inflammation and oxidative stress in respiratory and limb muscles of patients with severe sepsis]. Med Clin (Barc) (2012) 0.75
Development of PLGA-mannosamine nanoparticles as oral protein carriers. Biomacromolecules (2013) 0.75
Evaluation of the effectiveness of a bMSC and BMP-2 polymeric trilayer system in cartilage repair. Biomed Mater (2017) 0.75